[{"AccountsPayableCurrent_0_Q3_USD":5830000.0,"NumberOfBusinessesAcquired_3_Q3_business":2.0,"OperatingIncomeLoss_1_Q3_USD":-31711000.0,"OperatingIncomeLoss_3_Q3_USD":-114575000.0,"OperatingLeaseExpense_1_Q3_USD":1200000.0,"OperatingLeaseExpense_3_Q3_USD":3600000.0,"OperatingLeaseLiability_0_Q3_USD":36304000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":3803000.0,"NonoperatingIncomeExpense_3_Q3_USD":-13538000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":32501000.0,"OtherAssetsNoncurrent_0_Q3_USD":34871000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-100000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-714000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-100000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":-714000.0,"OtherLiabilitiesCurrent_0_Q3_USD":10056000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":43262000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":23807000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-2620000.0,"NonoperatingIncomeExpense_1_Q3_USD":-3885000.0,"NetIncomeLoss_1_Q3_USD":-35639000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":3819000.0,"InventoryValuationReserves_0_Q3_USD":3600000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":45188000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":6020000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":6578000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":6386000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":6200000.0,"NetIncomeLoss_3_Q3_USD":-128518000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1469000.0,"Liabilities_0_Q3_USD":467705000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":775075000.0,"LiabilitiesCurrent_0_Q3_USD":113163000.0,"LiabilitiesFairValueDisclosure_0_Q3_USD":81400000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":198470000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-144993000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":12085000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":8884000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":654000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-223000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_3_Q3_USD":2065000.0,"ShareBasedCompensation_3_Q3_USD":21524000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":6100000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":19.33,"StockGrantedDuringPeriodValueSharebasedCompensationGross_1_Q3_USD":3605000.0,"StockGrantedDuringPeriodValueSharebasedCompensationGross_3_Q3_USD":6679000.0,"StockholdersEquity_0_Q3_USD":307370000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":228000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":107808000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":1938000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":194157000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":6757000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":21524000.0,"TemporaryEquityForeignCurrencyTranslationAdjustments_1_Q3_USD":216000.0,"TemporaryEquityForeignCurrencyTranslationAdjustments_3_Q3_USD":1091000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":59230881.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":60803045.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":0.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":36065000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":170241000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":68217000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":502141000.0,"PaymentsToAcquireIntangibleAssets_3_Q3_USD":14004000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":4947000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PreferredStockSharesAuthorized_0_Q3_shares":20000000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockValue_0_Q3_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":7504000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":376100000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":376099000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":6679000.0,"ProceedsFromStockPlans_3_Q3_USD":1275000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":11513000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":48407000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":148160000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-714393000.0,"InventoryNet_0_Q3_USD":6616000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":59230881.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":2797000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":-4899000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":302465000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":98392000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":-5675000.0,"BusinessCombinationContingentConsiderationLiability_0_Q3_USD":81400000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":150327000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":150327000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":150327000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":400857000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":65555000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"CommonStockSharesIssued_0_Q3_shares":61018229.0,"CommonStockSharesOutstanding_0_Q3_shares":61018229.0,"CommonStockValue_0_Q3_USD":6000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-35523000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-128141000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":16069000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":24084000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":400866000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":108000.0,"AccountsReceivableNetCurrent_0_Q3_USD":13370000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-1311000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":63308000.0,"AccruedSalariesCurrent_0_Q3_USD":16896000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-525000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1022282000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":6986000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":117000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":22190000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":6344000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":18432000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":17984802.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":18012120.0,"Assets_0_Q3_USD":775075000.0,"AssetsCurrent_0_Q3_USD":579079000.0,"AssetsFairValueDisclosure_0_Q3_USD":551184000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":8356000.0,"ConvertibleDebtFairValueDisclosures_0_Q3_USD":280100000.0,"ConvertibleDebtNoncurrent_0_Q3_USD":223696000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":1592000.0,"ForeignCurrencyTransactionGainLossRealized_3_Q3_USD":1091000.0,"Goodwill_0_Q3_USD":936000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-35596000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-128113000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":43000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":405000.0,"IncomeTaxReceivable_0_Q3_USD":405000.0,"ForeignCurrencyTransactionGainLossRealized_1_Q3_USD":216000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":1908000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":40153000.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":-17006000.0,"IncreaseDecreaseInInventories_3_Q3_USD":380000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":2045000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":-237000.0,"InterestIncomeExpenseNet_1_Q3_USD":360000.0,"InterestIncomeExpenseNet_3_Q3_USD":1757000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-2577000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":148676000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":278395000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":129719000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":4888000.0,"CostsAndExpenses_1_Q3_USD":99928000.0,"CostsAndExpenses_3_Q3_USD":284816000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q3_USD":0.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q3_USD":400866000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q3_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q3_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q3_USD":197840000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q3_USD":117000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q3_USD":197840000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q3_USD":117000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":20567000.0,"EarningsPerShareBasic_1_Q3_USD":-0.59,"EarningsPerShareBasic_3_Q3_USD":-2.17,"EarningsPerShareDiluted_1_Q3_USD":-0.59,"EarningsPerShareDiluted_3_Q3_USD":-2.17,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-7000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":-15072000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":60803045.0,"Ticker":"TVTX","CIK":"1438533","name":"TRAVERE THERAPEUTICS, INC.","OfficialName":"Travere Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1905907401.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211029"}]